首页> 外文期刊>Biochemical and Biophysical Research Communications >Upregulation of Orail and STIM1 expression as well as store-operated Ca~(2+) entry in ovary carcinoma cells by placental growth factor
【24h】

Upregulation of Orail and STIM1 expression as well as store-operated Ca~(2+) entry in ovary carcinoma cells by placental growth factor

机译:通过胎盘生长因子向牛井和溶酶1表达以及卵巢癌细胞中的储存Ca〜(2+)进入的上调性

获取原文
获取原文并翻译 | 示例
           

摘要

Placental growth factor (P1GF) is produced by tumor cells and stimulates tumor growth and metastasis in part by upregulation of hypoxia inducible factor HIF1alpha. Orchestration of tumor cell proliferation and migration involves oscillations of cytosolic Ca~(2+) activity ([Ca~(2+)]j). The [Ca~(2+)]j oscillations could be accomplished by triggering of intracellular Ca~(2+) release followed by store-operated Ca~(2+)-entry (SOCE). Mechanisms accomplishing SOCE include the pore-forming ion channel unit Orail and its regulator STIM1. The present study explored whether P1GF influences the expression of Orail and STIM1, as well as SOCE and whether this effect impacts on HIFla expression.To this end, ovary carcinoma cells were cultured for 24 h without and with P1GF (lOng/ml). Orail, STIMl and HIFla transcript levels were quantified utilizing RT-PCR and Orail, STIM1 and HIFla protein levels by Western blotting. [Ca~(2+)]j was estimated from Fura-2-fluorescence and SOCE from increase of [Ca~(2+)]_i following Ca~(2+) re-addition after Ca~(2+)-store depletion with extracellular Ca~(2+) removal and sar-coendoplasmatic Ca~(2+)-ATPase (SERCA) inhibitor thapsigargin (1 muM).
机译:胎盘生长因子(P1GF)由肿瘤细胞产生,并通过缺氧诱导因子HIF1α的上调来刺激肿瘤生长和转移。肿瘤细胞增殖和迁移的角度涉及细胞溶质Ca〜(2+)活性的振荡([Ca〜(2 +)] J)。可以通过触发细胞内Ca〜(2+)释放,然后进行储存的Ca〜(2 +) - 进入(SOCE)来实现[Ca〜(2 +)] J振荡。完成脱离的机制包括孔形成离子通道单元逆转带及其调节器型肌肉。本研究探讨了P1GF是否会影响逆转录和溶性的表达,以及菌鹿以及这种影响是否对HIFLA表达产生影响。至于该末端,培养卵巢癌细胞24小时,没有P1GF(长/ mL)。通过Western印迹使用RT-PCR和OraI,Stim1和Hifla蛋白水平来定量逆转录,STIML和HIFLA转录水平。从CA〜(2+)之后的[Ca〜(2 +)] _ i的增加,从呋喃-2-荧光和脱离估计[Ca〜(2 +)] j〜(2+) - 商店用细胞外Ca〜(2+)去除和SAR-COENDOPLAMATIAG CA〜(2 +) - ATP酶(SERCA)抑制剂ThapsIgrin(1妈妈)耗尽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号